Semen enhances transmitted/founder HIV-1 infection and only marginally reduces antiviral activity of broadly neutralizing antibodies
Journal of Virology · 2024
DOI: 10.1128/jvi.01190-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Pascal von Maltitz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Virology, University Ulm Medical Center, Ulm, Germany. Hauptthemen laut MEDLINE: Anti-Infective Agents, HIV Infections, HIV-1, Semen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG).
Abstract (Originalsprache)
Topically applied microbicides may play a critical role in preventing sexual transmission of human immunodeficiency virus type 1 (HIV-1); however, their efficacy can be compromised by amyloid fibrils present in semen, which significantly increase HIV-1 infectivity. This phenomenon may have contributed to the failure of most microbicide candidates in clinical settings. Understanding the impact of semen on microbicide effectiveness is thus crucial. In our study, we evaluated the influence of semen on the neutralizing activity of broadly neutralizing antibodies (bNAbs), including PG16, PGT121, 10–1074, 3BNC117, and VRC01, which are potential microbicide candidates. We found that semen enhances infection of HIV-1 transmitted/founder viruses but only marginally affects the neutralizing activity of tested antibodies, suggesting their potential for microbicide application. Our findings underscore the need to consider semen-mediated enhancement when evaluating and developing microbicides and highlight the potential of incorporating HIV-1 bNAbs in formulations to enhance efficacy and mitigate HIV-1 transmission during sexual encounters. IMPORTANCE This study examined the impact of semen on the development of microbicides, substances used to prevent the transmission of HIV-1 during sexual activity. Semen contains certain components that can render the virus more infectious, posing a challenge to microbicide effectiveness. Researchers specifically investigated the effect of semen on a group of powerful antibodies called broadly neutralizing antibodies, which can neutralize a large spectrum of different HIV-1 variants. The results revealed that semen only had a minimal effect on the antibodies' ability to neutralize the virus. This is promising because it suggests that these antibodies could still be effective in microbicides, even in the presence of semen. Understanding this interaction is crucial for developing better strategies to prevent HIV-1 transmission. By incorporating the knowledge gained from this study, scientists can now focus on creating microbicides that consider the impact of semen, bringing us closer to more effective prevention methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Virology, University Ulm Medical Center, Ulm, Germany.
- Laboratory of Experimental Immunology, Institute of Virology, University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
- German Center for Infection Research, Partner site Bonn-Cologne, Cologne, Germany.
- Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
- Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
ORCID-Profile: Pascal von Maltitz, Philipp Schommers, Florian Klein, Jan Münch
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
Zitieren
APA
von Maltitz, P., Wettstein, L., Weil, T., Schommers, P., Klein, F., & Münch, J. (2024). Semen enhances transmitted/founder HIV-1 infection and only marginally reduces antiviral activity of broadly neutralizing antibodies. Journal of Virology. https://doi.org/10.1128/jvi.01190-23
Vancouver
von Maltitz P, Wettstein L, Weil T, Schommers P, Klein F, Münch J. Semen enhances transmitted/founder HIV-1 infection and only marginally reduces antiviral activity of broadly neutralizing antibodies. Journal of Virology. 2024. doi:10.1128/jvi.01190-23
BibTeX
@article{vonMaltitz2024,
author = {von Maltitz, Pascal and Wettstein, Lukas and Weil, Tatjana and Schommers, Philipp and Klein, Florian and Münch, Jan},
title = {Semen enhances transmitted/founder HIV-1 infection and only marginally reduces antiviral activity of broadly neutralizing antibodies},
journal = {Journal of Virology},
year = {2024},
doi = {10.1128/jvi.01190-23}
}
EUVIMED